IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB

被引：0

作者：

Nash, P. ^{[1
,2
]}

Mcinnes, I. ^{[3
]}

Ritchlin, C. T. ^{[4
]}

Tam, L. S. ^{[5
]}

Soriano, E. ^{[6
]}

Starr, M. ^{[7
]}

Rampakakis, E. ^{[8
,9
]}

Lavie, F. ^{[10
]}

Shawi, M. ^{[11
]}

Baraliakos, X. ^{[12
,13
]}

Mease, P. J. ^{[14
,15
]}

机构：

[1] Griffith Univ, Maroochydore, Australia

[2] Univ Queensland, Rheumatol Res Unit, Maroochydore, Australia

[3] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Scotland

[4] Univ Rochester, Dept Med Allergy Immunol & Rheumatol, Med Ctr, Rochester, NY USA

[5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[6] Hosp Italiano Buenos Aires, Rheumatol, Buenos Aires, Argentina

[7] McGill Univ, Div Rheumatol, Hlth Ctr, Montreal, PQ, Canada

[8] McGill Univ, Dept Pediat, Montreal, PQ, Canada

[9] JSS Med Res Inc, Sci Affairs, Montreal, PQ, Canada

[10] Janssen Cilag Global Med Affairs, Immunol Global Med Affairs, Issy Les Moulineaux, France

[11] Janssen Pharmaceut Co Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA

[12] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany

[13] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[14] St Joseph Hlth, Seattle, WA USA

[15] Univ Washington, Rheumatol Res, Seattle, WA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

bDMARD; Pain; Psoriatic arthritis; BIOLOGIC-NAIVE; DOUBLE-BLIND;

D O I：

10.1136/annrheumdis-2023-eular.555

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB1095

引用

页码：1771 / 1772

页数：2

共 50 条

[1] Impact of Psoriatic Arthritis Manifestations on Perception of Pain Improvement: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies with Guselkumab
Nash, Peter
McInnes, Iain
Ritchlin, Christopher T.
Tam, Lai-Shan
Soriano, Enrique
Starr, Michael
Rampakakis, Emmanouil
Lavie, Frederic
Shawi, May
Baraliakos, Xenofon
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2785 - 2787
[2] GUSELKUMAB EFFICACY IN ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS BY BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
Deodhar, Atul
Mease, Philip J.
Boencke, Wolf-Henning
Tesser, John
Schiopu, Elena
Chakravarty, Soumya D.
Kollmeier, Alexa P.
Hsia, Elizabeth C.
Xu, Xie L.
Shawi, May
Jiang, Yusang
Sheng, Shihong
Agarwal, Prasheen
Merola, Joseph F.
McInnes, Iain B.
Ritchlin, Christopher T.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S108 - S109
[3] Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies
Deodhar, Atul
Mease, Philip
Boehncke, Wolf-Henning
Tesser, John
Schiopu, Elena
Chakravarty, Soumya
Kollmeier, Alexa
Hsia, Elizabeth
Xu, Xie
Shawi, May
Jiang, Yusang
Sheng, Shihong
Agarwal, Prasheen
Merola, Joseph
McInnes, Iain
Ritchlin, Christopher
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[4] SUSTAINED GUSELKUMAB RESPONSE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS REGARDLESS OF BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS THROUGH WEEK 52 OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
Ritchlin, C. T.
Mease, P. J.
Boehncke, W. H.
Tesser, J.
Schiopu, E.
Chakravarty, S. D.
Kollmeier, A.
Hsia, E. C.
Xu, X. L.
Shawi, M.
Jiang, Y.
Sheng, S.
Merola, J. F.
McInnes, I.
Deodhar, A.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1291 - 1292
[5] Guselkumab Efficacy in Active Psoriatic Arthritis Patients with or Without Hyperuricemia: Post-hoc Analysis of Two Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
Felten, Renaud
Widawski, Laura
Spielman, Lionel
Gottenberg, Jacques-Eric
Duret, Pierre-Marie
Rampakakis, Emmanouil
Sharaf, Mohamed
Constantin, Caren
Campana, Vincenza
Messer, Laurent
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4429 - 4432
[6] Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials
Siebert, Stefan
Sweet, Kristen M.
Ritchlin, Christopher T.
Hsia, Elizabeth C.
Kollmeier, Alexa P.
Xu, Xie L.
Seridi, Loqmane
Song, Qingxuan
Gao, Sheng
Chen, Warner
Miron, Michelle
ACR OPEN RHEUMATOLOGY, 2023, 5 (09) : 490 - 498
[7] GUSELKUMAB EFFECT ON INFLAMMATORY CARDIOVASCULAR (CV) RISK BIOMARKERS, EFFICACY, AND SAFETY IN PSORIATIC ARTHRITIS PATIENTS WITH CV RISK FACTORS: POST-HOC ANALYSIS OF 2 PHASE 3, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDIES
Kavanaugh, A.
Soriano, E.
Dutz, J.
Selmi, C.
Yu, J.
Rampakakis, E.
Shawi, M.
Bravo Perdomo, A. M.
Lavie, F.
Coates, L.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1770 - 1771
[8] EFFICACY OF GUSELKUMAB ACROSS BASDAI COMPONENTS IN TREATING AXIAL-RELATED SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
Behrens, F.
Mease, P. J.
Helliwell, P.
Shawi, M.
Noel, W.
Chakravarty, D.
Kollmeier, A.
Xu, X. L.
Xu, S.
Wang, Y.
Baraliakos, X.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1289 - 1290
[9] Efficacy of Guselkumab Across BASDAI Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-controlled Studies
Behrens, Frank
Mease, Philip
Helliwell, Philip S.
Shawi, May
Noel, Wim
Chakravarty, Soumya
Xu, Alexa Kollmeier Xie
Xu, Xie
Xu, Stephen
Wang, Yanli
Baraliakos, Xenofon
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3778 - 3780
[10] INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS
Rahman, P.
Ritchlin, C.
Helliwell, P.
Boehncke, W. H.
Mease, P.
Gottlieb, A. B.
Kafka, S.
Kollmeier, A.
Hsia, E.
Xu, X. L.
Shawi, M.
Sheng, S.
Zhou, B.
Ramachandran, P.
McInnes, I.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1218 - 1218

← 1 2 3 4 5 →